Are clinical trials of therapeutic agents for MS long enough?
Rudge
P
P
National Hospital for Neurology and Neurosurgery, London, UK.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D012107:Research Design; D012460:Sulfasalazine / Q000627:therapeutic use*; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine; D016899:Interferon-beta